Trendlines Group Ltd. engages in the investment and development of medical and agricultural technology companies. The company invests principally through four business units: two Israeli government-franchised incubators, Trendlines Medical and Trendlines Agtech, a Singapore incubator, Trendlines Medical Singapore, and an in-house innovation center, Trendlines Labs. The Group’ s portfolio include more than 50 companies engaged with medical and agricultural technologies and products. The Group is involved in all aspects of its portfolio companies from technology development to business building. The Group in partnerships with entrepreneurs, investors, strategic players, inventors, and governments aims to improve the human condition.
根据最新的财务报表(Form-10K),The Trendlines Group Ltd. 的总资产为 $85,净利润为 $1
TRNGF 的关键财务比率是什么?
The Trendlines Group Ltd. 的流动比率是 12.14,净利 margin 为 0,每股销售为 $0。
The Trendlines Group Ltd. 的收入按细分市场或地理位置如何划分?
The Trendlines Group Ltd. 最大收入来源是 Innovative Agrifood Tech and Medical Device,在最近的收益报告中收入为 -661,522。就地区而言, Israel 是 The Trendlines Group Ltd. 的主要市场,收入为 -661,522。